Browse By Region

Browse By Category
Recent News
By Category: Countermeasures
HHS aids development of next generation broad spectrum antibiotic
(Press Release) The U.S. Department of Health and Human Services today issued a contract for advanced development of a novel antibiotic that potentially could treat illnesses caused by biological threats, such as anthrax and plague, as well as treat bacterial pneumonia and certain life-threatening bacterial infections associated with prolonged hospitalization.
- January 26, 2012
- | Filed under North America, Countermeasures, Policy & Initiatives, and Public Health
Congresswoman Jenkins Sends President Obama Letter on NBAF
(Press Release) Congresswoman Lynn Jenkins released the following statement after sending the attached letter to President Obama asking for his continued support of the National Bio and Agro-Defense Facility (NBAF) in Manhattan, Kansas: “Both the Bush and Obama administrations have made it exceedingly clear that the National Bio and Agro-Defense Facility (NBAF) is essential to Read More »
- January 25, 2012
- | Filed under North America, Countermeasures, Policy & Initiatives, and Research
Pentagon Seeking Ideas on Biothreat Detectors
(Global Security Newswire) The U.S. Defense Department is seeking suggestions from the private sector for potential creation of a compact device that could be carried by combat troops to pinpoint and classify biological warfare materials or other dangerous disease threats, Military & Aerospace Electronics magazine reported on Thursday. The Pentagon’s Defense Threat Reduction Agency emphasized it Read More »
- January 24, 2012
- | Filed under North America, Biotechnology, and Countermeasures
Carnegie Mellon study reveals potential of manganese in neutralizing deadly Shiga toxin
(EurekAlert!) Carnegie Mellon researchers have discovered that manganese, an element commonly found in nature, might provide a way to neutralize the potentially lethal effects Shiga toxin. New results published in the Jan. 20 issue of Science could pave the way for future research aimed at creating an inexpensive treatment for infections caused by bacteria that Read More »
- January 20, 2012
- | Filed under North America, Countermeasures, and Research
Soligenix Demonstrates Robust Stability Results with its SGX204 Anthrax Vaccine
(Sacramento Bee) SGX204 is a hyperimmunogenic derivative of PA and is being developed as a vaccine to protect against anthrax disease either as a pre-exposure prophylactic vaccine or post-exposure vaccine. Positive stability was demonstrated when DNI rPA was subjected …
- January 19, 2012
- | Filed under North America, Countermeasures, and Research